Pharmaceutical

Pathos AI raises $365m for oncology drug development

Pathos AI has raised $365m in a Series D funding round to widen its AI-enabled platform to advance the development of oncology drugs.

May 16, 2025 - 06:00
Pathos AI raises $365m for oncology drug development
Pathos AI has raised $365m in a Series D funding round to widen its AI-enabled platform to advance the development of oncology drugs.
Read the original article

Tags:

Previous Article

Are regulators keeping pace with AI adoption in clinical trials?

Next Article

FDA awards cancer drug approvals to AbbVie and MSD

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: BMI as a barrier to orthopedic surgery doesn’t make sense for patient health

Opinion: BMI as a barrier to orthopedic surgery doesn’t...

Jan 16, 2024

Lyell goes all in on CAR-T therapies, buys ImmPACT Bio and trims pipeline

Lyell goes all in on CAR-T therapies, buys ImmPACT Bio ...

Oct 26, 2024

Opinion: STAT+: How to make the EU’s new Joint Clinical Assessment process work for industry — and for patients

Opinion: STAT+: How to make the EU’s new Joint Clinical...

Oct 20, 2023